InsidersTradesSigma
Follow the Bacil Pharma stock price and the full management transaction log of the company, a listed issuer based in India. Shares are quoted on IN IN, under the oversight of SEBI (PIT + SAST). Market capitalisation: €538.1m. The latest transaction was reported on 16 July 2026 (Disposal). Among the most active insiders: Nikita Hiren Patel. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations
Bacil Pharma is a pharmaceutical company operating in the XBOM market. It focuses on the development and commercialization of innovative pharmaceutical products.